F-Prime Capital

F-Prime Capital

Signal active

Investment Firm

Overview

F-Prime's roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, this venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx.

Today, F-Prime's funds are larger and more global, but its teams are still small and local. F-Prime stays true to its entrepreneurial roots. In the US and Europe, F-Prime Capital Partners is investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, its sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai.

Together F-Prime brings a world of insight, domain expertise and relationships to support entrepreneurs. Without the pressure of fundraising from outside investors, F-Prime Capital Partners focuses all of its time finding and helping great entrepreneurs build important companies.

Highlights

Founded

1946

Industry

Financial Services

Employees

11-50

Investment

457

Lead Investment

115

Exits

91

Stages

Early Stage Venture, Late Stage Venture, Seed, Private Equity

Investor Type

Venture Capital

Location

United States, North America

Contact Information

Social

Profile Resume

F-Prime Capital, established in 1946 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Biotechnology, Medical, Therapeutics, Financial Services, Venture Capital, Finance, Consumer, Health Care, Manufacturing, Medical Device. The organization boasts a portfolio of 456 investments, with an average round size of $60.4M and 91 successful exits. Their recent investments include Proteostasis Therapeutics, New Enterprise Associates, HealthCare Ventures, Novartis Venture Fund, Sanofi Ventures. The highest investment round they participated in was $2158.1B. Among their most notable exits are Proteostasis Therapeutics and New Enterprise Associates. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Stephen Knight

Stephen Knight

President & Managing Partner

imagePlace Robert Weisskoff

Robert Weisskoff

Partner

imagePlace Davina Magargal

Davina Magargal

Director of Marketing

imagePlace Carl Byers

Carl Byers

Partner

imagePlace Thomas R. Beck

Thomas R. Beck

Executive Partner

imagePlace Mary Bevelock Pendergast

Mary Bevelock Pendergast

CFO, Partner

Investment portfolio

F-Prime Capital has made 457 investments. Their most recent investment was on Jul 09, 2024, when Canoe raised $36.0M.

F-Prime Capital has made 84 diversity investments. Their most recent diversity investment was on Jun 27, 2024, when Odaseva raised $54.0M.

investments

457

Diversity investments

84

Lead investments

115

Number of exits

91

Investments

457

Annouced DateOrganization NameIndustryMoney Raised
Jun 27, 2024
Odaseva Odaseva
Enterprise Software54.0M
Jun 27, 2024
RareCyte RareCyte
Biotechnology20.0M
Jul 09, 2024
Canoe Canoe
FinTech36.0M
Jul 25, 2024--4.0M

Exits

91

Funding Timeline

Funding rounds

457

Investors

0

Funds

0

Funding Rounds

457

F-Prime Capital has raised 457 rounds. Their latest funding was raised on Jul 25, 2024 from a Seed Round - Kintsu round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jun 27, 2024
Series C - Odaseva Series C - Odaseva
-54.0M-
Jun 27, 2024
Venture Round - RareCyte Venture Round - RareCyte
-20.0M-
Jul 09, 2024
Series C - Canoe Series C - Canoe
-36.0M-
Jul 25, 2024
Seed Round - Kintsu Seed Round - Kintsu
-4.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.